Exploration of the Combination of PLK1 Inhibition with Immunotherapy in Cancer Treatment.
Mengyuan LiZhixian LiuXiao-Sheng WangPublished in: Journal of oncology (2018)
Our findings implicate that the PLK1 inhibition and immunotherapy combination may achieve a synergistic antitumor efficacy.
Keyphrases